• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Creos International suspends shares

Article

X-ray generator developer Creos International of Fife, Scotland, has been encountering financial problems of late. The company last month requested that its shares be suspended from trading on the Alternative Investment Market of the U.K. while it

X-ray generator developer Creos International of Fife, Scotland, has been encountering financial problems of late. The company last month requested that its shares be suspended from trading on the Alternative Investment Market of the U.K. while it “considers its financial position.” The company has closed its subsidiary, Creos Limited, and is seeking the appointment of a provisional liquidator.

The company’s compact x-ray generator technology will live on, however. In December, Creos Limited’s U.S. subsidiary, Creos Inc., sold its business and assets to Colorado businessman Peter Cooper, who founded a new, private company, Creos Technologies of Englewood, CO. Creos Technologies employs 33 people and manufactures the high-powered, high-frequency x-ray generators initially developed by Creos International (SCAN 7/13/94). Creos International holds a residual interest in the new company.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.